Prime
Treatments
Testing and Advancements Index
The Prime Treatments, Testing and Advancements Index is designed to track both event-driven news and long-term trends of companies engaged in developing treatments and vaccines, or diagnostic technology, in the fight against infectious diseases.
FACT SHEET
Prime Treatments, Testing and Advancements Primer
PDF
Infectious Diseases: Prime Treatments, Testing and Advancements Overview
PDF
Prime Treatments, Testing and Advancements Index Methodology Guide
PDF
Prime Treatments, Testing and Advancements Factsheet
PDF
Prime Treatments, Testing and Advancements Index
VIDEO
INDEX KEY FACTS
Base Date: December 12, 2019
Total number of holdings:
62
Launch date: June 08, 2020
Reconstitution: Quarterly (March, June, September and December)
Index calculation agent: Solactive AG
Weighting scheme: Modified Market Capitalization
INDEX SYMBOLS
| Version | Bloomberg | Reuters | ISIN |
|---|---|---|---|
| Prime Treatments, Testing and Advancements Index GTR | PGERM | .PGERMG | DE000SL0A030 |
| Prime Treatments, Testing and Advancements Index NTR | N/A | .PGERMN | DE000SL0A022 |
| Prime Treatments, Testing and Advancements Index PR | N/A | .PGERMP | DE000SL0A014 |
INDEX COMPOSITION
| Component Name | Ticker | Weight |
|---|---|---|
| MODERNA INC | MRNA | 6.49% |
| BIONTECH SE | BNTX | 5.95% |
| QUEST DIAGNOSTICS INC | DGX | 5.66% |
| BIO-RAD LABORATORIES INC | BIO | 5.56% |
| LABORATORY CRP OF AMER HLDGS | LH | 5.53% |
| QUIDEL CORP | QDEL | 4.73% |
| ADAPTIVE BIOTECHNOLOGIES CORP | ADPT | 4.44% |
| NOVAVAX INC | NVAX | 4.35% |
| VIR BIOTECHNOLOGY INC | VIR | 4.21% |
| ALNYLAM PHARMACEUTICALS INC | ALNY | 3.99% |
| ZAI LAB LTD | ZLAB | 3.72% |
| EMERGENT BIOSOLUTIONS INC | EBS | 3.69% |
| CUREVAC BV | CVAC | 3.31% |
| INOVIO PHARMACEUTICALS INC | INO | 2.98% |
| VAXCYTE INC | PCVX | 2.94% |
| I-MAB | IMAB | 2.39% |
| OPKO HEALTH INC | OPK | 2.26% |
| VBI VACCINES INC | VBIV | 1.59% |
| DICERNA PHARMACEUTICALS INC | DRNA | 1.53% |
| LUMINEX CORP | LMNX | 1.20% |
| ARCTURUS THERAPEUTICS HOLDINGS INC | ARCT | 1.05% |
| TRANSLATE BIO INC | TBIO | 1.03% |
| VAXART INC | VXRT | 1.00% |
| ENANTA PHARMACEUTICALS INC | ENTA | 0.94% |
| ORASURE TECHNOLOGIES INC | OSUR | 0.89% |
| NANTKWEST INC | NK | 0.87% |
| MERIDIAN BIOSCIENCE INC | VIVO | 0.77% |
| ALEXION PHARMACEUTICALS INC | ALXN | 0.70% |
| BIOCRYST PHARMACEUTICALS INC | BCRX | 0.70% |
| ASTRAZENECA PLC-SPONS ADR | AZN | 0.68% |
| TAKEDA PHARM-ADR | TAK | 0.67% |
| REGENERON PHARMACEUTICALS | REGN | 0.67% |
| PFIZER INC | PFE | 0.66% |
| ELI LILLY & CO | LLY | 0.66% |
| ABBOTT LABORATORIES | ABT | 0.65% |
| BRISTOL-MYERS SQUIBB CO | BMY | 0.65% |
| SANOFI-ADR | SNY | 0.64% |
| ABBVIE INC | ABBV | 0.64% |
| MERCK & CO. INC. | MRK | 0.64% |
| GILEAD SCIENCES INC | GILD | 0.64% |
| JOHNSON & JOHNSON | JNJ | 0.63% |
| GLAXOSMITHKLINE PLC-SPON ADR | GSK | 0.63% |
| XBIOTECH INC | XBIT | 0.62% |
| SIGA TECHNOLOGIES INC | SIGA | 0.59% |
| ASSEMBLY BIOSCIENCES INC | ASMB | 0.58% |
| DYNAVAX TECHNOLOGIES CORP | DVAX | 0.56% |
| CEL-SCI CORP | CVM | 0.54% |
| CUE BIOPHARMA INC | CUE | 0.50% |
| CO-DIAGNOSTICS INC | CODX | 0.44% |
| ATHERSYS INC | ATHX | 0.41% |
| IBIO INC | IBIO | 0.41% |
| OXFORD IMMUNOTEC GLOBAL PLC | OXFD | 0.34% |
| IMV INC | IMV | 0.33% |
| PARATEK PHARMACEUTICALS INC | PRTK | 0.30% |
| ARBUTUS BIOPHARMA CORP | ABUS | 0.26% |
| HOOKIPA PHARMA INC | HOOK | 0.26% |
| CHIMERIX INC | CMRX | 0.19% |
| CORMEDIX INC | CRMD | 0.18% |
| ENOCHIAN BIOSCIENCES INC | ENOB | 0.17% |
| CONTRAFECT CORP | CFRX | 0.16% |
| ENZO BIOCHEM INC | ENZ | 0.11% |
| PHASEBIO PHARMACEUTICALS INC | PHAS | 0.10% |